Skip to content

Impact of long-term apple consumption on the gut microbiota including Akkermansia

Impact of long-term apple consumption on the gut microbiota including Akkermansia - Impact of apple consumption on the gut microbiota

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000052142
Enrollment
40
Registered
2024-03-31
Start date
2023-01-13
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Japanese men and women between 40 and 65 years old with a BMI between 18.5 kg/m2 and 30.0 kg/m2

Interventions

One apple per day (300 g edible portion excluding peel and core) daily for 12 weeks

Sponsors

Food Research Institute, National Agriculture and Food Research Organization
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Subjects who fully understand the significance, content, and purpose of this study and have given written consent to participate in this study. (2) Japanese men and women between the ages of 40 and 65 years (3) BMI between 18.5 kg/m2 and 30.0 kg/m2

Exclusion criteria

Exclusion criteria: (1)Those who regularly take supplements that contain ingredients that may affect the results of this study(2) Those who are participating in other clinical trials at the start of this study(3) Who have ever complained of physical discomfort due to ingestion of apples or polyphenols(4) Patients with a history of heart failure or myocardial infarction(5) Excluded due to diseases(6) Those suffering from serious cerebrovascular disease, cardiac disease, liver disease, renal disease, gastrointestinal disease, or infectious disease requiring notification.(7) Those who have a history of major surgery on the digestive system, such as gastrectomy, gastrointestinal suture, or intestinal resection(8) Those with significant abnormalities in physical measurements, blood pressure measurements, or blood tests(9) Those with a low hemoglobin level(10) Women around menopause who show significant changes in their physical condition(11) Persons who may show allergic symptoms to drugs or foods(12) Excessive smokers: smokers who generally smoke 21 or more cigarettes per day(13) Regular users of alcohol: Those who generally drink more than 20 g of pure alcohol per day(14) Those whose lifestyle is extremely irregular: frequently skip two or more meals, eat out for dinner almost every day, work night shifts, or do not regularly take days off(15) Women who have donated 400 mL blood within 16 weeks prior to the start of intake, men who have donated 400 mL blood within 12 weeks prior to the start of intake, and those who have donated 200 mL blood within 4 weeks or component blood within 2 weeks prior to the start of intake(16) Women who are pregnant or possibly pregnant, or lactating(17) Any participant in any other clinical trial, observational study, clinical trial, or home use test between 4 weeks prior to the start of the study period and the end of the intake period(18) Any other person deemed ineligible by the principal investigator

Design outcomes

Primary

MeasureTime frame
Gut microbiota analysis using feces

Secondary

MeasureTime frame
Physical measurements (height, weight, BMI, visceral fat area), blood tests (TC, LDL-C, HDL-C, TG, total bile acid, fasting blood glucose, HbA1c, insulin, (AST, ALT, gamma-GTP, ALP, LDH, 1.5-AG, total bile acid, CRP), dietary habits questionnaire (health food intake , diet and exercise habits, drinking and smoking habits, sleep duration), short-chain fatty acids, urinary metabolites

Countries

Japan

Contacts

Public ContactToshihiko Shoji

Food Research Institute, National Agriculture and Food Research Organization Division of Food Function Research

tshoji@affrc.go.jp029-838-8041

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026